95
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Is it time to re-think the use of etravirine in patients with available genotypic resistance test?

, , , , , , , & show all
Pages 452-455 | Received 01 Dec 2018, Accepted 08 Jan 2019, Published online: 30 Apr 2019
 

Disclosure statement

No potential conflict of interest was reported by the authors.

Acknowledgements

We would like to thank the ARCA database and the ARCA mentor school for their support.

 

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.